$IVVD 3 SEC Filings

Filed On	Filing
02 Sep 2026	Form 3: Sheffield Ian, Director No securities owned
04 Aug 2026	Form 3: Mina Michael, CMO and Chief Epidemiologist
24 Sep 2025	Form 3: Bolno Paul, Director No securities owned
26 Mar 2025	Form 3: Royan Ajay, Director Holds 11,241,580 shares of Common Stock
06 Jun 2024	Form 3: Lee Timothy Edward, Chief Commercial Officer No securities owned
23 May 2024	Form 3: Mclaughlin Kevin F, Director No securities owned
23 May 2024	Form 3: Gupta Srishti, Director No securities owned
26 Jan 2024	Form 3: Green Julie, Chief Human Resources Officer
05 Sep 2023	Form 3: Duke William E., Chief Financial Officer No securities owned
27 Jul 2023	Form 3: Cotter Sara, Director Holds 1,000 shares of Common Stock
12 Apr 2023	Form 3: Allen Robert D. Iii, Chief Scientific Officer No securities owned
28 Mar 2023	Form 3: Price Stacy, Chief Tech. and Manuf. Officer No securities owned
16 Dec 2022	Form 3: Gowler Jeremy, COO & CCO No securities owned
06 Dec 2022	Form 3: Schmidt Peter, Chief Medical Officer Holds 6,971 shares of Common Stock
24 Oct 2022	Form 3: Lindenboom Christine, Director No securities owned
13 Oct 2022	Form 3: Driscoll Frederick W, Interim CFO No securities owned
24 Jun 2022	Form 3: Berry Tamsin, Director No securities owned
01 Apr 2022	Form 3: Elia Marc, SEE REMARKS and 1 other Holds 6,398,250 shares of Common Stock, par value $0.0001
30 Mar 2022	Form 3: Meanwell Clive, See Explanation of Responses. Holds 1,201,680 shares of Common Stock
30 Mar 2022	Form 3: Cox Christopher T, See Explanation of Responses Holds 679,822 shares of Common Stock

Comments